INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 58 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | -100.0% | 330 | -94.2% | 0.00% | -100.0% |
| Q1 2017 | $23,000 | +283.3% | 5,709 | +258.2% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 1,594 | +19.8% | 0.00% | -100.0% |
| Q4 2015 | $9,000 | -47.1% | 1,331 | -35.1% | 0.00% | 0.0% |
| Q3 2015 | $17,000 | -54.1% | 2,050 | -12.7% | 0.00% | -66.7% |
| Q2 2015 | $37,000 | – | 2,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|